ロード中...
Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
OBJECTIVE: To present current strategies for the treatment of hemophilia and von Willebrand's disease. OPTIONS: Prophylactic and corrective therapy with hemostatic and adjunctive agents: DDAVP (1-desamino-8-D-arginine vasopressin [desmopressin acetate]), recombinant coagulation products (human...
保存先:
| フォーマット: | Artigo |
|---|---|
| 言語: | Inglês |
| 出版事項: |
1995
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1338053/ https://ncbi.nlm.nih.gov/pubmed/7600466 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|